Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bonomo

Showing results (121-130 of 884) with videos related to

Pageof 89
Sort By:
Drug Discovery Today|October 4, 2020
Efflux pumps as interventions to control infection caused by drug-resistance bacteriaNabeela Farhat, Abid Ali, Robert A Bonomo, et al.
Southern Medical Journal|September 30, 2003
Deep fascial space infection of the neck: a continuing challengeNashaat S Hamza, John Farrel, Melvin Strauss, et al.
Antimicrobial Agents and Chemotherapy|January 16, 2007
Use of novel boronic acid transition state inhibitors to probe substrate affinity in SHV-type extended-spectrum beta-lactamasesJodi M Thomson, Fabio Prati, Christopher R Bethel, et al.
Virulence|April 19, 2011
Are we closing in on an "elusive enemy"? The current status of our battle with Acinetobacter baumanniiFederico Perez, Rafael Ponce-Terashima, Mark D Adams, et al.
Biochimica Et Biophysica Acta|June 15, 1999
OHIO-1 beta-lactamase mutants: the Arg244Ser mutant and resistance to beta-lactams and beta-lactamase inhibitorsS Lin, M Thomas, S Mark, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2020
Reply to Vena et alJason M Pogue, Keith S Kaye, Robert A Bonomo, et al.
The Journal of Antimicrobial Chemotherapy|March 8, 2023
Gepotidacin: a novel, oral, 'first-in-class' triazaacenaphthylene antibiotic for the treatment of uncomplicated urinary tract infections and urogenital gonorrhoeaRichard R Watkins, Dipendra Thapaliya, Tracy L Lemonovich, et al.
Australian Journal of Primary Health|February 16, 2023
<i>Corrigendum to</i>: Use of electronic medical records to monitor the safe and effective prescribing of medicinal cannabis: is it feasible?Christine M Hallinan, Jane M Gunn, Yining Qian, et al.
Expert Review of Molecular Diagnostics|December 20, 2014
Salvage microbiology: opportunities and challenges in the detection of bacterial pathogens following initiation of antimicrobial treatmentJohn J Farrell, Andrea M Hujer, Rangarajan Sampath, et al.
Biochemistry|September 10, 2009
Why the extended-spectrum beta-lactamases SHV-2 and SHV-5 are "hypersusceptible" to mechanism-based inhibitorsMatthew Kalp, Christopher R Bethel, Robert A Bonomo, et al.
Pageof 89

Showing results (121-130 of 884) with videos related to

Sort By:
Pageof 89
Drug Discovery Today|October 4, 2020
Efflux pumps as interventions to control infection caused by drug-resistance bacteriaNabeela Farhat, Abid Ali, Robert A Bonomo, et al.
Southern Medical Journal|September 30, 2003
Deep fascial space infection of the neck: a continuing challengeNashaat S Hamza, John Farrel, Melvin Strauss, et al.
Antimicrobial Agents and Chemotherapy|January 16, 2007
Use of novel boronic acid transition state inhibitors to probe substrate affinity in SHV-type extended-spectrum beta-lactamasesJodi M Thomson, Fabio Prati, Christopher R Bethel, et al.
Virulence|April 19, 2011
Are we closing in on an "elusive enemy"? The current status of our battle with Acinetobacter baumanniiFederico Perez, Rafael Ponce-Terashima, Mark D Adams, et al.
Biochimica Et Biophysica Acta|June 15, 1999
OHIO-1 beta-lactamase mutants: the Arg244Ser mutant and resistance to beta-lactams and beta-lactamase inhibitorsS Lin, M Thomas, S Mark, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2020
Reply to Vena et alJason M Pogue, Keith S Kaye, Robert A Bonomo, et al.
The Journal of Antimicrobial Chemotherapy|March 8, 2023
Gepotidacin: a novel, oral, 'first-in-class' triazaacenaphthylene antibiotic for the treatment of uncomplicated urinary tract infections and urogenital gonorrhoeaRichard R Watkins, Dipendra Thapaliya, Tracy L Lemonovich, et al.
Australian Journal of Primary Health|February 16, 2023
<i>Corrigendum to</i>: Use of electronic medical records to monitor the safe and effective prescribing of medicinal cannabis: is it feasible?Christine M Hallinan, Jane M Gunn, Yining Qian, et al.
Expert Review of Molecular Diagnostics|December 20, 2014
Salvage microbiology: opportunities and challenges in the detection of bacterial pathogens following initiation of antimicrobial treatmentJohn J Farrell, Andrea M Hujer, Rangarajan Sampath, et al.
Biochemistry|September 10, 2009
Why the extended-spectrum beta-lactamases SHV-2 and SHV-5 are "hypersusceptible" to mechanism-based inhibitorsMatthew Kalp, Christopher R Bethel, Robert A Bonomo, et al.
Pageof 89